New York Got More Than 900 Retail Applications. What's Next?

Stakeholders say there are still more questions than answers.

New York state regulators received 903 applications for the first round of retail cannabis licenses, by the time the application window closed last Monday, an obvious demonstration of the sky-high interest in the upcoming adult-use industry.

But looking forward, stakeholders say there are still more questions than answers swirling around the business landscape, which is making it hard – if not impossible – to solidify plans.

The state reserved the first round of applications for those with cannabis-related criminal records and nonprofits that work with those harmed by the war on drugs. But stakeholders said the state Office of Cannabis Management hasn’t made firm decisions on:

  • How many retail licenses will be issued. Media reports including from The New York Times have put the number at 150, plus an additional 25 for nonprofits, for a total of 175 initial retail permits.
  • When social equity retail licenses will be awarded.
  • When the 10 existing medical marijuana businesses in the state can selling recreational cannabis themselves.
  • When the general public will be allowed to apply for retail permits.

Uncertainty for industry insiders

State officials have repeatedly said they hope to have sales launch by the end of 2022, but with far more regulatory uncertainty than clarity, that goal may prove elusive, said New York City attorney Lauren Rudick, who shepherded six applications in for social equity clients.

“We know they’re going to take the next 30 days or so to review the applications,” Rudick said, when asked what’s next in the licensing process. “What we know is we’re faced with a lot of uncertainty.”

Rudick said there isn’t much that’s been announced, and there are a host of questions, including when $50 million in state monies for upwards of 150 social equity retail locations will be actually put to use.

“We have no transparency or visibility into how they’re going to review these” applications, Rudick said.

That sentiment is echoed by Ngiste Abebe, president of the New York Medical Cannabis Industry Association.

“It’s very exciting to see where we are with the (adult-use) program so far in New York, but we have a lot of other questions left, because it’s a big program to be rolled out,” Abebe said.

John Schroyer

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 2 hours

Schwazze Loses $18.5 Million Despite ‘Record’ Revenue

@GreenMarketRpt – 8 hours

Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.